News Related to Bavarian Nordic

Related coverage linked through entity extraction aliases.

Moderna Faces Key FDA Decision on mRNA Flu Vaccine Amid Pipeline Push and Financial Scrutiny

Jul 16, 2026

Moderna awaits an August 2026 FDA decision on its mRNA flu vaccine while expanding into oncology, autoimmune disease, and monkeypox. Its COVID-19 vaccine Spikevax remains central amid financial losses and cautious analyst sentiment.

HER2-Positive Gastric Cancer Pipeline Expands with 20+ Therapies in Development

Mar 22, 2026

Over 20 pharmaceutical companies are developing therapies for HER2-positive gastric cancer, with multiple Phase III trials launched in March 2026 testing novel combination treatments for advanced disease.